Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $11.5M | $20.1M | $15.5M | $26.4M | $37.2M | $20.4M | $20.4M |
| Operating income | −$13.9M | −$24.2M | −$20.9M | −$35.6M | −$46.9M | −$32.0M | −$32.3M |
| EBITDA | −$14.1M | −$24.5M | −$21.6M | −$35.6M | −$47.2M | −$33.2M | −$32.0M |
| Net income | −$14.2M | −$24.5M | −$21.6M | −$35.6M | −$47.3M | −$32.8M | −$33.4M |
| Net margin | — | — | — | — | — | — | — |
| EPS (diluted) | -0.93 | -1.60 | -4.79 | -1.72 | -2.13 | -1.01 | -1.03 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ALNA.
No tracked institution reports a position in ALNA as of their last filing.
No one on the platform has traded ALNA yet.
| $9M |
| — |
| EPIXESSA Pharma Inc. | $0.20 | -1.85% | $10M | — |
| IMVIFIMV Inc. | $0.00 | +0.00% | $23423 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.